Research map: Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study

Back to the article

Papers in this map

  1. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer · Thomas B. Powles · 2024 · 1079 citations · Cited by this paper
  2. Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies · 2026 · Related
  3. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation · Joseph M. Unger · 2018 · 585 citations · Cited by this paper
  4. The Utility of the Comprehensive Complication Index in Demonstrating the Complication Burden and Predicting Length of Stay in Robot-Assisted Radical Prostatectomy · 2026 · Related
  5. Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence · Christopher M. Booth · 2014 · 481 citations · Cited by this paper
  6. Real-World Effectiveness and Tolerability of Belzutifan in Sporadic Clear Cell Renal Cell Carcinoma: A Retrospective Cohort Study With Exploratory Genomic Correlation · 2026 · Related
  7. Use of Electronic Health Record Data for Quality Reporting · Amy P. Abernethy · 2017 · 60 citations · Cited by this paper
  8. Exploration of the Challenges in the Management of Prostate Cancer in East Africa · 2025 · Related
  9. Real-world Uptake of Enfortumab Vedotin plus Pembrolizumab after US Food and Drug Administration Approval Among Patients with Advanced Urothelial Cancer · Ronac Mamtani · 2024 · 8 citations · Cited by this paper
  10. Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications—A Systematic Review · 2026 · Related
  11. Guidelines versus real-world data in metastatic bladder cancer: A population-based study on first-line chemotherapy treatment patterns · Ellis Slotman · 2024 · 4 citations · Cited by this paper
  12. Impact of Age on Outcomes in Metastatic Non–Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT) · 2026 · Related
  13. Efficacy and Safety of Every Other Week Gemcitabine and Docetaxel (GEMDOC) in Heavily Pretreated Metastatic Castration Resistant Prostate Cancer: A Retrospective Real-world Analysis · 2026 · Related
  14. A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer · 2025 · Related
  15. Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules · 2025 · Related
  16. Why Has Prostate Cancer Research Lagged Behind? Advocacy, Biology, and the Road Ahead · 2026 · Related

Source: OpenAlex (CC0)